Conclusions Although there has been progress in avoiding severe hypoglycemia from 2005 to 2013, the increased number of isolated older diabetic elderly seems to have counteracted clinicians' efforts. A patient-centered approach that sets individualized glycemic targets and selects treatment that balances efficacy and safety is key to avoiding severe hypoglycemia. Improved social support for diabetic elderly patient is also important.
Introduction
It has been well established that tight glycemic control can reduce the risk of microangiopathy both in type 1 and type 2 diabetes [1] [2] [3] . Severe hypoglycemic events, however, that occur during the process of tight glycemic control, may increase morbidity and mortality [4, 5] . In older diabetic patients, particularly, hypoglycemic events may be related to increases in cognitive impairment [6] , falls [7] , depression [8] , disturbed quality of life [9] , and mortality [10] .
We previously reported the incidence and characteristics of diabetic medication-induced severe hypoglycemic cases in the emergency department (ED) of our hospital from 2005 to 2006 [11] . We pointed out earlier that (1) [60 % of the cases occurred in subjects[70 years of age, and (2) among these older patients, hypoglycemia occurred more frequently in those with stage 3-5 chronic kidney disease (CKD). We emphasized that care should be taken with treating diabetes in older subjects with CKD stage 3-5 [11] .
Recently, there has been growing recognition that an individualized approach is important for managing diabetes [12, 13] , particularly in older patients [14] . Furthermore, some new anti-hyperglycemic medicines have been developed during the past decade (e.g., DPP-4 inhibitors [15] , long-acting insulin analogs [16] ) that are associated with a lower risk of hypoglycemia than sulphonylureas and conventional insulin treatments.
We therefore hypothesized that the safety of treatments for diabetes should have improved accordingly. To verify our hypothesis, we compared the incidence and characteristics of diabetic medication-induced severe hypoglycemic cases at our ED during 2012-2013 with those during [2005] [2006] .
Research design and methods
In this retrospective observational study, we investigated the clinical characteristics of diabetic medication-induced severe hypoglycemic cases in the ED of Asahikawa Red Cross Hospital during two 16 Diabetic medication-induced severe hypoglycemic events, defined as (1) presence of conscious disturbance caused by hypoglycemia, (2) use of insulin and/or oral hypoglycemic agents (OHA), (3) requirement for intravenous glucose injection for treatment and (4) blood glucose level \70 mg/dL measured at the ED, were collected by reviewing electronic medical records of the hospital.
In patients who took sulfonylureas (SUs), SU doses were converted to glimepiride as follows: glimepiride 2 mg = glibenclamide 1.25 mg = gliclazide 40 mg. The conversion rate among SUs was determined based on the reports of dose titration for antidiabetic agents in geriatrics [17] and the usual doses of SUs prescribed in Japan [18] .
The estimated glomerular filtration rate (eGFR) was calculated using the modified Modification of Diet in Renal Disease Study equation for Japanese [19] . The glycosylated hemoglobin (HbA 1c ) values, measured as Japan Diabetes Society values were converted to National Glycohemoglobin Standardization Program values [20] .
This study was approved by the Ethics Committee of Asahikawa Red Cross Hospital.
Statistical analysis
Comparisons between the groups were carried out using the Chi-squared test, Student's t test, or Wilcoxon rank-sum test as appropriate. All analyses were performed using IBM SPSS statistics software (version 22; IBM SPSS, Armonk, NY, USA). The results were expressed as the mean ± SD, and a p value of less than 0.05 was considered to be statistically significant.
Results
The clinical characteristics of patients in the two periods are shown in Table 1 . The emergency department of Asahikawa Red Cross Hospital has the largest stroke unit in the north Hokkaido area, and covers patients with consciousness disturbance including hypoglycemia with a population of *300,000 inhabitants.
As shown in Table 1 , the total number and incidences of diabetic medication-induced hypoglycemia as a proportion of all emergency visits were almost identical during the two research periods. However, the hospitalization rate of hypoglycemic patients was significantly lower (Fig. 2b) .
Diabetes treatments in the two groups are shown in Table 1 . All patients with type 1 diabetes during both study periods were treated with a basal-bolus insulin regimen. In type 2 diabetic patients, the rate of insulin and OHA use were similar in the two groups. In all, 20 type 2 diabetic patients in both groups were treated with insulin alone. (Table 1 ).
All patients with hypoglycemia treated with OHA were prescribed SUs. The mean SU dose, converted to glimepiride, was 3. Twice-daily 8 5
Three times or more (type 1 diabetes) 14 (3) 17 ( Case 1 A 75 year-old type 2 diabetic woman who lived alone and used twice-daily premixed insulin analog lost her consciousness before lunch and was found by neighbor who visiting her by chance. Her blood glucose level was 31 mg/dL at the time of arrival at the ED.
Case 2 An 83 year-old type 2 diabetic man who lived at an institution for the elderly lost consciousness and was transported to the ED by ambulance at 4:30 am. His blood glucose level was 20 mg/dL at the time of arrival at the ED. He had lost his appetite and thus had reduced food intake for the 3 days before the event. He nevertheless was given the usual dose of SU (2.5 mg of glibenclamide) every morning by the care staff of the institution.
Discussion
In the present study, the absolute numbers and the rates of diabetic medication-induced severe hypoglycemia had not changed between the two investigation periods that were 7 years apart.
In 2005, when we started the investigation, the benefit of tight glycemic control to prevent diabetic complications was confirmed by the results of the Diabetes Control and Complications Trial [1] , the UK Prospective Diabetes Study [2] , and the Kumamoto study [3] . However, the true risks and benefits of tight glycemic control in high-risk patients with type 2 diabetes were unknown [21] . After the publication of the Action to Control Cardiovascular Risk in Diabetes (ACCORD), Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation (ADVANCE), and the Veteran's Affairs Diabetes Trial (VADT) [22] , the principle of glycemic control in type 2 diabetes changed to emphasize 'patient-centered approach', which meant setting a glycemic target individually with regard to the patient's disease features including the risk of hypoglycemia [12] . The Japan Diabetes Association made the same recommendation that glycemic control objectives should be established individually and should include consideration of age, duration of disease, organ damage, risk of hypoglycemia, and support structures [13] . We therefore anticipated that the incidence of [24] .
Too stringent glycemic targets and potential overtreatment of diabetes especially for older patients, may have contributed to our results for the patients during the earlier period (2005) (2006) . Others who have reported hypoglycemia in older individuals expressed the same findings [25, 26] . In the present study, the mean HbA 1c level of hypoglycemic patients during 2005-2006 was 6.72 % overall and 6.06 % in patients aged [75 years. These values seem too low for older patients [14] . In our investigation, 36 of 48 patients These changes may reflect a change in doctors' attention to the risk of hypoglycemia. Therefore, too stringent glycemic targets is thought not to be the main reason why the number of cases of hypoglycemia at the ED had not shown a decrease during 2012-2013 in the present study.
The rapid increase in the number of people with diabetes, especially among older adults, may have affected the results. According to the reports of the National Institute of Health and Nutrition of Japan, the estimated population of patients with diabetes was 7.4 million in 2003 and 9.5 million in 2013. In 2013, the estimated prevalence of diabetes among adults aged C70 years was 23.2 % in men and 16.7 % in women. The increase in elderly diabetic patients may also increase the possibility of emergent hypoglycemia, even if clinicians set a less-stringent glycemic target than before. Renal insufficiency could raise the risk of hypoglycemia. In our study, 51.2 % of the patients during 2005-2006 and 66.0 % during 2012-2013 had CKD stage 3-5. Also, the mean HbA 1c of patients with CKD stages 3-5 was lower than that of those with CKD stage 1-2 during both observation periods. Clearance of insulin and active metabolites of SUs is delayed in patients with renal insufficiency [10] . Thus, to avoid hypoglycemia, clinicians should decrease the dose of insulin or SU, according to the decline in GFR.
The change in social background of Japanese older individuals may also have contributed to the results. In the present study, 39.6 % of patients during 2005-2006 and 55.3 % of patients during 2012-2013 were C75 years of age. As shown in Table 2 , the number of patients living alone increased by 63 %, and those living with younger family members decreased by 50 % during 2012-13 compared with that during 2005-2006. In older diabetic patients, symptoms of hypoglycemia are non-specific [28] , and blood glucose levels may fall to a dangerous level without any awareness of hypoglycemia [29] . Comorbidities such as cognitive disturbance or functional impairment may also cause a delay in the accurate management of a hypoglycemic event. As shown in case 1, the absence of person who attend to signs of hypoglycemia of older adults with diabetes may increase the risk of severe hypoglycemia.
The number of patients living in institutions for older individuals increased during 2012-2013. There is a greater chance that hypoglycemia will be noticed by the staff members working in the institutions. However, as shown in case 2, more education about diabetes and its treatment should be necessary for the staff members working at these institutions to avoid severe hypoglycemic event of the inhabitants.
In the present study, a high proportion of type 2 diabetic patients received insulin mono therapy during 2005-2006 (47.6 %) and 2012-2013 (51.3 %). Among the type 2 diabetic patients who received insulin monotherapy, a three-times-daily or basal-bolus insulin regimen was common during both observation periods. Because of the limited information obtainable from the ED medical records, we were unable to determine whether these insulin regimens were appropriate for those individuals. However, in general, implementation of a basal-bolus insulin regimen may be difficult for the majority of older patients because it requires frequent blood glucose monitoring and active titration to achieve good glycemic control and avoid hypoglycemia [30] . Rather than insulin monotherapy, the combination of long-acting insulin and OHA, called ''basal insulin supported oral therapy,'' may reduce the risk of hypoglycemia [31] . The number of patients who received this combination of insulin and OHA was small in the present study (Table 1) .
The safety and efficacy of DPP-4 inhibitors in older patients with type 2 diabetes has been reported [15] . The DPP-4 inhibitors have been used from 2009 in Japan, and the number of prescriptions for type 2 diabetes patients has rapidly increased. In the present study, DPP-4 inhibitors were prescribed in 20.9 % of type 2 diabetes patients during 2012-2013. By using DPP-4 inhibitors in combination therapy, it should be possible to reduce insulin and/ or SU doses and also reduce risk of hypoglycemia, without interfering with adequate glycemic control [32] . In 2012, the prescribing rate of DPP-4 inhibitor for patients with type 2 diabetes in Asahikawa Red Cross Hospital was 49.8 % (unpublished data). DPP-4 inhibitors should be used more widely, especially in elderly patients with type 2 diabetes.
There are some limitations to the present study. First, it is a retrospective observational study from the ED of a single hospital. Therefore, the results may not entirely reflect the trend of severe hypoglycemic events in this country. Second, because the clinical information obtainable from the ED medical records was so limited, except in the case of hospitalization, we could not adequately assess previous therapy or complications in each patient. Nevertheless, we hope the results of the present study may help towards establishing safe and effective treatment for diabetes, especially in older individuals.
In conclusion, severe hypoglycemic cases did not decrease from 2005 to 2013 in our ED.
Clinical data have suggested some progression in the treatment of diabetes from 2005 to 2013 in terms of avoiding severe hypoglycemia. However, further efforts of clinicians are expected in the treatment of elderly patients with diabetes. A patient-centered approach involving setting individualized glycemic targets and careful selection of treatment with regard to balancing its efficacy and safety should be the key to avoiding severe hypoglycemia.
An increase in the number of elderly patients with diabetes and an acceleration of the isolation of these patients in the society seems to have contributed to the results.
Improving social support for the older individual is important. It is also important to educate not only the medical staff but also the care staff members working in the institutions for older individuals about diabetes and diabetes treatment.
